NCT03799315 (JUST) is a NA clinical trial of Nicotine Replacement Therapy in Tobacco Use, sponsored by Hennepin Healthcare Research Institute.

Who is sponsoring NCT03799315?

NCT03799315 is sponsored by Hennepin Healthcare Research Institute.

What drugs are being tested in NCT03799315?

Interventions in NCT03799315: Nicotine Replacement Therapy, Counseling.

What condition does NCT03799315 study?

NCT03799315 studies Tobacco Use.

Is NCT03799315 still recruiting?

NCT03799315 is currently completed. Last updated 14 September 2020.

Last reviewed 2020-09-14 · How we verify

NCT03799315: JUST

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Jail-Based Use of Smoking Cessation Treatment Study

Completed NA Last updated 14 September 2020

What this trial tests

NA trial testing Nicotine Replacement Therapy in Tobacco Use in 66 participants. Completed in 29 August 2020.

Timeline

14 January 2019

Primary endpoint
16 March 2020

29 August 2020

Quick facts

Lead sponsor	Hennepin Healthcare Research Institute
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	66
Start date	14 January 2019
Primary completion	16 March 2020
Estimated completion	29 August 2020
Sites	1 location across United States

Drugs / interventions tested

Nicotine Replacement Therapy — full drug profile →
Counseling

Conditions studied

Tobacco Use — all drugs for Tobacco Use →

Sponsor

Hennepin Healthcare Research Institute

Who can join

Adults 18 to 64, any sex, with Tobacco Use. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Smoking rates remain above 60% for individuals involved in the criminal justice system and contribute to elevated mortality rates in this population. Addressing smoking disparities among justice-involved individuals is a critical public health issue in Minnesota, one of a few states with rising incarceration rates. People who are incarcerated represent the intersection of multiple high-priority populations (disproportionately African-American, Native American, low-income, homeless, on Medicaid, and suffering from mental illness and substance use disorders). This study examines the impact of a smoking cessation intervention for individuals discharged from jail to the community on smoking abstinence. Participants will be randomized to either 1) guideline-based, in-person smoking cessation counseling during incarceration, telephone counseling after incarceration, and nicotine replacement, or 2) enhanced treatment as usual. This study's findings will be used to develop a larger, multi-site study that is fully powered to measure longer-term health and smoking cessation outcomes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Feasibility and Acceptability of a Smoking Cessation Program for Individuals Released From an Urban, Pretrial Jail: A Pilot Randomized Clinical Trial.
Winkelman TNA, Ford BR, Dunsiger S, Chrastek M, et al · · 2021 · cited 14× · PMID 34228127 · DOI 10.1001/jamanetworkopen.2021.15687

Verify or expand the search:

Other trials of Nicotine Replacement Therapy

Trials testing the same drug.

NCT06063421 — Comparison of Nicotine Replacement Therapy and Electronic Cigarettes for Smoking Cessation in Pakistan · NA · unknown
NCT05628389 — Phone Enabled Implementation of Cessation Support · NA · recruiting
NCT05030766 — Testing Integrative Smoking Cessation for HIV Patients · Phase 4 · completed
NCT04965181 — Mindfulness-based Smoking Cessation Enhanced With Mobile Technology · NA · completed
NCT04590404 — Metabolism Informed Smoking Treatment: The MIST RCT · Phase 3 · completed

Other recruiting trials for Tobacco Use

Currently open trials in the same condition.

NCT07162935 — Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY) · NA · recruiting
NCT07132814 — Abuse Liability for Five Modern Oral Nicotine Products · NA · recruiting
NCT07148232 — Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness · Phase 4 · recruiting
NCT06983678 — Neural Correlates and Behavioral Impact of Withdrawal-induced Hyperalgesia Among People Who Smoke With and Without Chron · NA · recruiting
NCT06922617 — STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking · NA · recruiting

Other Hennepin Healthcare Research Institute trials

Trials by the same sponsor.

NCT07126795 — Magnesium Sulfate in Pediatric Burn Dressing Changes · Phase 1 · not yet recruiting
NCT06514547 — Vaccine Immunity and Inflammation in the Aging Person Living With HIV · Phase 4 · recruiting
NCT05879302 — Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision · NA · completed
NCT05627596 — Free Samples for Health · Phase 2 · enrolling by invitation
NCT05819749 — Diabetes Homelessness Medication Support Program in Spanish · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03799315 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hennepin Healthcare Research Institute
Last refreshed: 14 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03799315.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing